Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Widimsky

Showing results (91-100 of 232) with videos related to

Pageof 24
Sort By:
Journal of Thrombosis and Thrombolysis|November 7, 2009
An embolus in the right atrium caught in the Chiari network and resistant to thrombolysisZuzana Motovska, Petr Widimsky, Dana Bilkova, et al.
Cardiology|January 31, 2015
Variants in miRNA regulating cardiac growth are not a common cause of hypertrophic cardiomyopathyKarol Curila, Lucie Benesova, Pavol Tomasov, et al.
International Journal of Cardiovascular Interventions|March 8, 2003
Cardioprotective effects of adenosine transport inhibition during reversible ischaemia in patients with coronary artery diseaseJan Paul Ottervanger, Pavel Gregor, Petr Widimsky, et al.
Journal of the American College of Cardiology|October 2, 2007
Severe left ventricular dyssynchrony is associated with poor prognosis in patients with moderate systolic heart failure undergoing coronary artery bypass graftingMartin Penicka, Jozef Bartunek, Otto Lang, et al.
American Heart Journal|May 8, 2004
Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACSTimo Lenderink, Eric Boersma, Witold Ruzyllo, et al.
European Heart Journal|February 15, 2007
Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 TrialPetr Widimsky, Dana Bilkova, Martin Penicka, et al.
Circulation. Cardiovascular Interventions|December 3, 2015
One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 StudyPetr Widimsky, Robert Petr, Petr Tousek, et al.
Journal of Clinical Medicine|December 30, 2020
Modified Strategies for Invasive Management of Acute Coronary Syndrome during the COVID-19 PandemicPetr Toušek, Viktor Kocka, Petr Masek, et al.
Frontiers in Cardiovascular Medicine|January 23, 2023
Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trialsZuzana Motovska, Ota Hlinomaz, Michael Aschermann, et al.
Heart Rhythm|May 15, 2019
Five-year outcomes in cardiac surgery patients with atrial fibrillation undergoing concomitant surgical ablation versus no ablation. The long-term follow-up of the PRAGUE-12 StudyPavel Osmancik, Petr Budera, David Talavera, et al.
Pageof 24

Showing results (91-100 of 232) with videos related to

Sort By:
Pageof 24
Journal of Thrombosis and Thrombolysis|November 7, 2009
An embolus in the right atrium caught in the Chiari network and resistant to thrombolysisZuzana Motovska, Petr Widimsky, Dana Bilkova, et al.
Cardiology|January 31, 2015
Variants in miRNA regulating cardiac growth are not a common cause of hypertrophic cardiomyopathyKarol Curila, Lucie Benesova, Pavol Tomasov, et al.
International Journal of Cardiovascular Interventions|March 8, 2003
Cardioprotective effects of adenosine transport inhibition during reversible ischaemia in patients with coronary artery diseaseJan Paul Ottervanger, Pavel Gregor, Petr Widimsky, et al.
Journal of the American College of Cardiology|October 2, 2007
Severe left ventricular dyssynchrony is associated with poor prognosis in patients with moderate systolic heart failure undergoing coronary artery bypass graftingMartin Penicka, Jozef Bartunek, Otto Lang, et al.
American Heart Journal|May 8, 2004
Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACSTimo Lenderink, Eric Boersma, Witold Ruzyllo, et al.
European Heart Journal|February 15, 2007
Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 TrialPetr Widimsky, Dana Bilkova, Martin Penicka, et al.
Circulation. Cardiovascular Interventions|December 3, 2015
One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 StudyPetr Widimsky, Robert Petr, Petr Tousek, et al.
Journal of Clinical Medicine|December 30, 2020
Modified Strategies for Invasive Management of Acute Coronary Syndrome during the COVID-19 PandemicPetr Toušek, Viktor Kocka, Petr Masek, et al.
Frontiers in Cardiovascular Medicine|January 23, 2023
Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trialsZuzana Motovska, Ota Hlinomaz, Michael Aschermann, et al.
Heart Rhythm|May 15, 2019
Five-year outcomes in cardiac surgery patients with atrial fibrillation undergoing concomitant surgical ablation versus no ablation. The long-term follow-up of the PRAGUE-12 StudyPavel Osmancik, Petr Budera, David Talavera, et al.
Pageof 24